translational oncologist at Duke Cancer Institute / director CLL & Lymphoma research program / views and tweets are my own
Joined December 2019
- Tweets67
- Following259
- Followers480
- Likes455
Danielle M. Brander retweeted
CME Opportunity: Join #DukeDebates2024, presented by #DukeCancerNetwork in collaboration with @DukeCancer.
April 12-14, 2024, Hilton Head, SC
Register here: bit.ly/DukeDebates
CME credit available. Earn up to 12 MOC Part 2 points.
#DukeCancerInstitute #MedEd
Danielle M. Brander retweeted
Ask your doctor if you are considered high risk by the CLLIPI score. If so, you may qualify for this exciting study. #CLL @SWOG @BrianHill_MDPhD @mshadman @anthonymatomd @dbranderMD @DanilovLab
Venetoclax + obinutuzumab combo is approved as front-line tx for pts w #CLL. Can intervening early w this combo vs waiting for symptoms lengthen survival for pts w high-risk (CLL-IPI of 4+) CLL or small #lymphocytic #lymphoma? @SWOG S1925 trial. SWOG.org/clinical-trials/S19… @NRGonc
Danielle M. Brander retweeted
Outstanding commentary by @DebbieMStephens from @huntsmancancer on the recent publication on the ELEVATE-RR study comparing ibrutinib and acalabrutinib in R/R CLL in @JCO_ASCO ascopubs.org/doi/abs/10.1200…
Danielle M. Brander retweeted
Just out - our multicenter effort to dissect comorbidities in CLL @mshadman @DrDanPersky @dbranderMD @matthew_mei @jonathonbcohen @KrishPatelMD @BrianHill_MDPhD @DebbieMStephens clincancerres.aacrjournals.o…
Danielle M. Brander retweeted
Thanks to the @CllSociety for all you do for our patients. Happy New Year!
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
Danielle M. Brander retweeted
Important MURANO tox ax
@anthonymatomd @jeff_sharman et al
28% premature d/c VR<2y
⬇️ PFS in prem d/c ven for any reason (PD excluded;p<0.0001)+due to AE
Interrupt for AE 69% / dose ⬇️ 23% both no impact on PFS/OS
Tox mx+continued Rx important for VenR PFS outcome #CLL #lymsm
Danielle M. Brander retweeted
#ASH20 poster by @LindsayReinMD @DukeHMCT @dukemedicine @DukeCancer
Phase I trial incorporating NK cells for patients w/ #CML & MRD after TKI therapy. #leusm
bit.ly/3osWQ7x
There may not have been an official ASH run this year, but anyone else still get in their #FauciFour ? If daily running is the secret to Dr Fauci leading the nation through this chaos, may I never stop.
Also, the San Diego skyline has nothing on my view.
#IRunForASH
Flashback Friday and my upcoming first Twitter-versary.
This tweet from an amazing #cll leader, along with a little help from @chadinabhan and @anthonymatomd finally got me on board. Looking forward to #ash20 highlights and my first ash on Twitter.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
To teach is to learn, twice
And thankful for this opportunity from #ASH20, twice -
to learn from so many others but also to work on this with an amazing fellow @DukeFellows, Dr Ashley Hanlon @amilliga, that has taught me so much and co authored this chapter #dukefamily
This Post is from an account that no longer exists. Learn more
Danielle M. Brander retweeted
We are so excited to welcome @_joycehwang @andrewpeseski @FahminB_MDPhD Drs. Kathrine DiNardo, Cameron Oswalt, Grayce Selig, and Cameron Wood to the Duke Heme/Onc Fellowship Program! We are so excited to have you join our wards and clinics in July 2021! @DukeCancer @dukemedicine
Intolerance is a failure of the medication for that given patient, patients don’t fail therapy.
Grateful to be a part of this collaborative effort @DukeHMCT and for all trials aimed at the unmet need of intolerance. @anthonymatomd @AndreaSitlinger and many others
This Post is from an account that no longer exists. Learn more
Danielle M. Brander retweeted
Please see our publication of the largest cohort of patients #Hodgkin transformation in #CLL patients. haematologica.org/article/vi… Planning more research in this patient population. Thanks for a great collaborative effort. @huntsmancancer @UUtah. @UofUHealth
Danielle M. Brander retweeted
Outcome of #Hodgkin arising from #CLL. collaboration led by @DebbieMStephens. haematologica.org/article/vi…
@dbranderMD @DrMDavids @anthonymatomd
@fredhutch @SeattleCCA – at Bellevue, WA
Danielle M. Brander retweeted
🎉🎉 Congratulations to @BarbAlexanderMD, who will be the new president of @IDSAInfo. "The critical role of ID physicians & scientists has never been more apparent as it is today."
idsociety.org/news--publicat…
every point exactly, @JasAWebb - easy to feel defeated hearing this news, but will take that energy and use it to inspire action towards the many challenges that face us...
This Post is from an account that no longer exists. Learn more